Description
Immunopeptidome Profiling Services As a trusted contract research organization, Cayman offers a full suite of services supported by our in-house expertise and strategic partnerships with industry leaders. Our immunopeptidome profiling services provide efficient, cost-effective deep sequence analysis of MHC-associated peptides for the identification of neoantigens and potential immunogenic sequences. Weve partnered with leading industry experts to provide a complete package for clients neoantigen discovery needs from isolation and sequencing of MHC-associated peptides to peptide synthesis and production.
- Identification of thousands of MHC-associated peptides
- Optimized workflow for MHC Class I and II (human or mouse)
- Allele-specific studies matched to your specifications
- Suitable for cells or tumor tissue
- Analysis using Orbitrap MS and unbiased, deep sequencing of the MHC peptidome
- Peptide synthesis and production
- Customized antibody production, cell culture, and bioanalysis services can be tailored to your specific project needs
MHC Class I and MHC Class II Neoantigen Discovery Neoantigen ID Genetic mutations in cancer cells can give rise to novel peptide sequences (neoantigens) that can be presented via the MHC-I pathway and potentially recognized by the immune system as foreign. Profiling (IDing) the immunopeptidome of established tumor cell lines or tumor tissue holds potential for the development of personalized antitumor immunotherapies designed to stimulate a patients immune response to neoantigen-derived epitopes.
MAPPs MHC class II associated peptide proteomics (MAPPs) is of growing importance as a drug development tool for biological therapeutics, as repeated administration can lead to immune-mediated neutralization and reduced long-term efficacy of recombinant protein and engineered antibody-based drugs. Cayman has optimized methods to enhance uptake of biologics by APCs, which, combined with specific MHC class II immunoprecipitation, results in improved efficiency in identifying potentially immunogenic epitopes in allele-specific patient subsets.
Neoantigen Discovery Services Our Neoantigen Discovery Services combine Caymans expertise in immunopeptidome profiling with GenScripts expertise in peptide synthesis to provide you with the complete package for neoantigen candidate discovery and development.